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BACKGROUND
Accumulating evidence suggests that new obli-
gate intracellular Chlamydia-like organisms may
play a role as human pathogens [1–3]. Waddlia
chondrophila, an abortigenic agent in bovines,
might play a role in human miscarriage [2], while
Parachlamydia acanthamoebae and Protochlamydia
naegleriophila represent new aetiologic agents of
pneumonia [1,3]. However, the modes of trans-
mission of these Chlamydia-related organisms and
the populations at risk for infection with these
strict intracellular bacteria are incompletely
deﬁned. Here, we tested sera taken from asymp-
tomatic men in Switzerland for antibodies direc-
ted against these Chlamydia-like organisms to
determine seroprevalence and to identify risks
factors for seropositivity, i.e. exposure to these
bacteria. Sera were also tested for a fourth
Chlamydia-related organism, Criblamydia sequanen-
sis [4], which was isolated from the water of the
Seine river and whose pathogenic role has not yet
been studied.
METHODS
Young Swiss men were enrolled in this cross-sectional study
during their medical examination for compulsory military
service [5]. Demographic data, animal exposure and sexual
risks factors were recorded using a questionnaire [5]. Sera
were ﬁrst screened by immunoﬂuorescence for antibody
reactivity against Waddlia chondrophila, C. sequanensis,
P. acanthamoebae and P. naegleriophila using as secondary
antibody FluolineH (BioMerieux, Marcy l’Etoile, France) as
reported [2]. Sera that exhibited a total Ig titre ‡1:64 were then
tested for IgG and IgM reactivity using corresponding anti-
human Ig ﬂuorescein (FluolineG or FluolineM, BioMerieux).
Each immunoﬂuorescence was read blindly by two indepen-
dent observers and congruent results were considered positive
(98.1% and 97.5% concordance for Waddlia and Criblamydia,
respectively). IgG and IgM positivity cut-offs were ‡1:64 and
‡1:32, respectively [2]. Positive immunoﬂuorescences were
conﬁrmed byWestern-blot, as described earlier [2]. Prevalence,
conﬁdence interval (95%CI) and odds ratio (OR) were calcu-
lated using STATA (College Station, TX, USA).
RESULTS
Among 517 young Swiss men enrolled [5], 482
gave their consent for blood sampling. Demo-
graphic characteristics and potential risk factors
for seropositivity for Chlamydia-like organisms are
shown in Table 1.
Among 66 volunteers (13.7%, 95% CI 10.6–
16.8) screened positive for Waddlia, 40 (8.3%, 95%
CI 5.9–11.3) had IgG antibodies against this agent.
Only three men (0.6%, 95% CI 0–1.3) exhibited
IgM antibodies against Waddlia. No speciﬁc risks
factors for Waddlia infection were identiﬁed.
A total of 101 subjects (21%, 95% CI 17.7–25.5)
were screened positive for Criblamydia. The preva-
lences of IgG and IgM antibody reactivity against
Criblamydia were 8.3% (40 ⁄ 482, 95% CI 5.9–11.3)
and 1.7% (8 ⁄ 482, 95% CI 0.5–2.8), respectively.
Presence of dogs at home was associated with
Criblamydia total Ig seropositivity, suggesting that
this Chlamydia-like organism may be zoonotically
transmitted. However, this association was
not observed when considering patients with IgG
or IgM positivity. Conversely, Criblamydia IgG
seropositivity was associated with asthma (OR 2.9,
95% CI 1.2–7.1). This association between Criblam-
ydia and asthma was stronger (OR 4.1, 95% CI 1.1–
15.6) when an IgG cutoff of ‡1 ⁄ 256 was chosen.
No volunteers exhibited signiﬁcant IgG or IgM
reactivity against Protochlamydia or Parachlamydia,
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although three men (0.6%, 95% CI 0.1–1.8) were
positive for Parachlamydia during the screening
phase that detected total antibody reactivity
against Parachlamydia. Positivity was conﬁrmed
by Western-blots (data not shown). The three
patients positive for Parachlamydia were negative
for all other Chlamydia-like organisms tested.
Interestingly, they lived in the same rural area
(within a less than 20 km radius) and two of them
were occupationally exposed to farm animals
(2 ⁄ 12 vs. 1 ⁄ 467, p 0.002).
Interestingly, 53.2% of IgG positive Criblamydia
serologies were positive for Waddlia. Conversely,
62.5% of IgG positive Waddlia serologies were
also positive for Criblamydia. None of the positive
serologies observed here were associated with
Chlamydia trachomatis infection [5]. To identify
cross-reacting immunogenic proteins, we per-
formed Western blot analyses on sera positive
only for Criblamydia and on sera positive for both
Waddlia and Criblamydia, using C. sequanensis as
antigen. Immunogenic proteins of 77, 69, 62, 57, 54
Table 1. Demogrphic characteristics, potential risk factors of chlamydial infection and underlying diseases according to
Waddlia and Criblamydia serostatus.
Characteristics
Total Waddlia positive Criblamydia positive
n (%) n (%) p-value* Odds ratio 95% Cl n (%) p-value* Odds ratio 95% Cl
Age (year ± SD) 20.6 ± 1.4 20.9 ± 1.7 20.8 ± 1.6
£20 264 54.8 20 50 0.619 ref 22 46.8 0.281 ref
>20 218 45.2 20 50 1.23 0.64–2.35 25 53.2 1.42 0.78–2.61
Nationality at birth
Switzerland 407 84.4 35 87.5 0.941 ref 42 89.4 0.408 ref
Europe 39 8.1 3 7.5 0.89 0.26–3.02 4 8.5 0.99 0.34–2.93
Other 36 7.5 2 5 0.63 0.14–2.71 1 2.1 0.25 0.03–1.86
Place of residence
>10 000 inhabitants 128 73.4 14 35 0.261 ref 8 17 0.163 ref
<10 000 inhabitants 354 26.6 26 65 1.55 0.78–3.07 39 83 0.54 0.24–1.19
Main occupation
Studies 218 45.2 20 50 0.949 ref 24 51.1 0.249 ref
Work 251 52.1 19 47.5 1.1 0.57–2.12 20 42.6 0.96 0.51–1.78
Declined to respond 13 2.7 1 2.5 0.96 0.12–7.79 3 6.4 2.84 0.73–11.02
Monthly income
<l000 Frs. 283 62.3 22 55 0.152 ref 24 51.1 0.048 ref
1000–2000 Frs. 64 14.1 2 5 0.38 0.09–1.67 3 6.4 0.53 0.15–1.82
>2000 Frs. 107 23.6 12 30 1.5 0.71–3.15 14 29.8 1.62 0.81–3.27
Declined to respond 28 5.8 4 10 1.98 0.63–6.21 6 12.8 2.94 1.09–7.96
Contact with animal 250 51.9 22 55 0.742 1.15 0.60–2.20 26 55.3 0.648 1.17 0.64–2.14
Farm animals 13 2.7 1 2.5 1 0.92 0.12–7.25 1 2.1 1 0.77 0.10–6.03
Dog 108 22.4 10 25 0.693 1.17 0.55–2.48 13 27.7 0.361 1.37 0.69–2.70
Cat 166 34.4 14 35 1 1.03 0.52–2.03 19 40.4 0.419 1.33 0.72–2.46
Smoke ⁄drugs
Cigarettes 225 46.7 12 30 0.46 0.23–0.93 20 42.6 0.645 0.83 0.45–1.53
Cannabis 125 25.6 10 25 1 0.95 0.45–2.00 10 21.3 0.489 0.75 0.36–1.56
Drugs 19 3.9 2 10.5 0.666 1.32 0.29–5.91 2 10.5 0.707 1.09 0.24–4.88
Alcohol > 2· ⁄week 326 67.6 24 60 0.293 0.7 0.36–1.35 28 59.6 0.251 0.68 0.37–1.26
Any reported disease 48 9.9 5 12.5 0.579 1.33 0.49–3.56 9 19.2 0.038 2.4 1.08–5.34
Asthma 32 6.6 4 10 0.326 1.64 0.55–4.94 7 14.9 0.027 2.87 1.17–7.05
Any regular treatment 52 10.8 9 17.3 0.028 2.69 1.20–6.03 10 19.2 0.024 2.53 1.17–5.45
Food
Vegetarian 6 1.2 1 2.5 0.407 2.24 0.26–19.7 1 2.1 0.462 1.87 0.21–16.35
Milk allergy 11 2.3 0 0 0 0 0.611 - -
Maternal feeding at birth 440 91.3 36 90 0.768 0.85 0.29–2.51 44 93.6 0.786 1.44 0.43–4.87
Drink
Water from city 377 78.2 31 77.5 0.844 ref 34 72.3 0.351 ref
Water in bottle 105 21.8 9 22.5 1.05 0.48–2.27 13 27.7 1.43 0.72–2.81
Sport practice ‡ 1· ⁄week 340 70.5 31 77.5 0.368 1.48 0.69–3.20 36 76.6 0.402 1.41 0.70–2.86
Number of life sexual partners
0 65 13.5 7 17.5 0.373 ref 7 14.9 0.643 ref
1 109 22.6 7 17.5 0.57 0.19–1.70 8 17 0.66 0.23–1.90
‡2 297 61.6 24 60 0.73 0.30–1.77 32 68.1 1 0.42–2.38
Declined to respond 11 2.3 2 5 1.84 0.33–10.3 0 0 - -
Sexual orientation
Heterosexual 363 75.3 29 72.5 0.282 ref 36 76.6 0.943 ref
Homo ⁄ bisexual 9 1.9 2 5 3.29 0.65–16.6 1 2.1 1.14 0.14–9.34
Declined to respond 110 22.8 9 22.5 1.02 0.47–2.24 10 21.3 0.91 0.44–1.90
Condom use
Always 156 32.4 12 30 0.189 ref 19 40.4 0.422 ref
Sometimes 224 46.5 16 40 0.93 0.42–2.01 22 46.8 0.78 0.41–1.51
Never 70 14.5 6 15 1.13 0.40–3.13 5 10.6 0.55 0.20–1.55
Declined to respond 32 6.6 6 15 2.77 0.95–8.04 1 2.1 0.24 0.03–1.80
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and 44 KDa were identiﬁed in both groups
(Fig. 1). Rate of positivity was higher in patients
with a concomitant positive Waddlia serology for
proteins exhibiting 62, 57 and 44 kDa, suggesting
that these proteins cross-reacted.
CONCLUSIONS
This work demonstrates that exposure of humans
to W. chondrophila and C. sequanensis is quite
common, while exposure to P. acanthamoebae and
P. naegleriophila may be limited. The Waddlia IgG
seroprevalence of 8.3% we observed here was
similar to that of 7.1% observed in 169 healthy
pregnant women in the UK [2].
To our knowledge, we describe here the
ﬁrst hint suggesting a possible association of
C. sequanensis with the presence of asthma.
Human infection might occur through exposure
to contaminated water. Indeed, C. sequanensis has
been isolated from water [4] and free-living
amoebae, which are widespread in water net-
works, may serve as hosts for Criblamydia [4].
Criblamydia and Parachlamydia might also be
zoonotically transmitted, because we observed
an association with dog exposure and farm
animals, respectively. However, these associa-
tions were only present when considering screen-
ing results.
The absence of anti-Parachlamydia IgG reactivity
observed in all 482 healthy subjects investigated
when considering an IgG titre ‡1 ⁄ 64 is consistent
with a report by Marrie et al. who did not identify
any seropositive subjects among 511 healthy
volunteers [1].
This work also shows some serological cross-
reactivity between Criblamydia and Waddlia and
conﬁrms the absence of cross-reactivity between
Parachlamydia and the other bacteria we investi-
gated here [2,3].
In conclusion, further investigations are
needed to conﬁrm whether C. sequanensis may
be involved in the pathogenesis of asthma and
whether C. sequanensis and P. acanthamoebae
should be, like W. chondrophila [2], considered as
zoonotic pathogens.
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Fig. 1. Representative western blot pattern of IgG positive
human sera tested using Criblamydia sequanensis as antigen.
Percentage of bands were calculated on 2 x 21 positive
sera.
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